| Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes D Castel, C Philippe, R Calmon, L Le Dret, N Truffaux, N Boddaert, ... Acta neuropathologica 130, 815-827, 2015 | 577 | 2015 |
| Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas S Puget, C Philippe, DA Bax, B Job, P Varlet, MP Junier, F Andreiuolo, ... PloS one 7 (2), e30313, 2012 | 261 | 2012 |
| Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes M Clarke, A Mackay, B Ismer, JC Pickles, RG Tatevossian, S Newman, ... Cancer discovery 10 (7), 942-963, 2020 | 210 | 2020 |
| Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors B Geoerger, D Hargrave, F Thomas, A Ndiaye, D Frappaz, F Andreiuolo, ... Neuro-oncology 13 (1), 109-118, 2010 | 168 | 2010 |
| Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma J Grill, S Puget, F Andreiuolo, C Philippe, L MacConaill, MW Kieran Pediatric blood & cancer 58 (4), 489-491, 2012 | 159 | 2012 |
| Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort N Lavoine, C Colas, M Muleris, S Bodo, A Duval, N Entz-Werle, F Coulet, ... Journal of medical genetics 52 (11), 770-778, 2015 | 134 | 2015 |
| Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical … JP Kilday, B Mitra, C Domerg, J Ward, F Andreiuolo, T Osteso-Ibanez, ... Clinical Cancer Research 18 (7), 2001-2011, 2012 | 117 | 2012 |
| Co‐occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma M Pagès, K Beccaria, N Boddaert, R Saffroy, A Besnard, D Castel, F Fina, ... Brain Pathology 28 (1), 103-111, 2018 | 106 | 2018 |
| Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens S Ladoire, K Chaba, I Martins, AQ Sukkurwala, S Adjemian, M Michaud, ... Autophagy 8 (8), 1175-1184, 2012 | 94 | 2012 |
| TMA for all: a new method for the construction of tissue microarrays without recipient paraffin block using custom-built needles ARC Pires, FM Andreiuolo, SR de Souza Diagnostic Pathology 1, 1-5, 2006 | 94 | 2006 |
| Childhood supratentorial ependymomas with YAP1‐MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features F Andreiuolo, P Varlet, A Tauziède‐Espariat, ST Jünger, E Dörner, ... Brain Pathology 29 (2), 205-216, 2019 | 90 | 2019 |
| YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis KW Pajtler, Y Wei, K Okonechnikov, PBG Silva, M Vouri, L Zhang, ... Nature communications 10 (1), 3914, 2019 | 77 | 2019 |
| Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB … D Figarella-Branger, E Lechapt-Zalcman, E Tabouret, S Jünger, ... Neuro-oncology 18 (7), 919-927, 2016 | 73 | 2016 |
| Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort J Pallud, ... Neuro-oncology 17 (12), 1609-1619, 2015 | 71 | 2015 |
| Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma N Truffaux, C Philippe, J Paulsson, F Andreiuolo, L Guerrini-Rousseau, ... Neuro-oncology 17 (7), 953-964, 2015 | 71 | 2015 |
| Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas F Andreiuolo, S Puget, M Peyre, C Dantas-Barbosa, N Boddaert, ... Neuro-oncology 12 (11), 1126-1134, 2010 | 71 | 2010 |
| Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging M Pagès, KW Pajtler, S Puget, D Castel, N Boddaert, A Tauziède‐Espariat, ... Brain Pathology 29 (3), 325-335, 2019 | 70 | 2019 |
| A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer G Fountzilas, A Fragkoulidi, A Kalogera-Fountzila, M Nikolaidou, M Bobos, ... Cancer chemotherapy and pharmacology 65, 649-660, 2010 | 70 | 2010 |
| Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis M Peyre, F Commo, C Dantas-Barbosa, F Andreiuolo, S Puget, L Lacroix, ... PloS one 5 (9), e12932, 2010 | 67 | 2010 |
| Clinical, imaging, histopathological and molecular characterization of anaplastic ganglioglioma M Zanello, M Pages, A Tauziède-Espariat, R Saffroy, S Puget, L Lacroix, ... Journal of Neuropathology & Experimental Neurology 75 (10), 971-980, 2016 | 64 | 2016 |
